Sector valuations Myriad Genetics, Inc.
Equities
MYGN
US62855J1043
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.230 USD | -1.63% |
|
+2.99% | -47.26% |
| Nov. 26 | Sector Update: Health Care Stocks Edge Higher Premarket Wednesday | MT |
| Nov. 25 | Myriad Genetics Collaborates With Clairity, MagView to Roll Out AI Platform for Breast Cancer Risk Assessment | MT |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | -1.8x | 1.87x | -0.01x | 0.81x | 21.35x | 86.8x | -.--% | 685M | |
| 26.54x | 2.71x | 3.3x | 2.93x | 12.03x | 17.59x | 0.87% | 14.35B | |
| -33.44x | -32.55x | 2.51x | 14.31x | -65.7x | -34.14x | -.--% | 13.3B | |
| -21.21x | - | 0.41x | 10.01x | 115.35x | -192.61x | - | 7.66B | |
| 27.68x | 4.91x | -3.49x | 9.64x | 22.18x | 24.32x | 2.02% | 6.6B | |
| 18.34x | - | -0.77x | 2.79x | 7.59x | 7.91x | - | 4.04B | |
| 18.08x | 1.76x | 22.54x | 3.13x | 9.46x | 13.47x | 1.92% | 3.83B | |
| 17.16x | 2.23x | 39.73x | - | - | - | 3.48% | 2.89B | |
| -34.09x | 2.82x | 0.52x | 2.87x | -31.43x | -23.08x | -.--% | 2.26B | |
| 41.45x | 1.32x | -3.15x | 5.44x | 17.91x | 29.94x | 0.75% | 1.97B | |
| 32.36x | 1.5x | 1.27x | - | - | - | 2.72% | 1.55B | |
| 22.13x | 1.71x | -1x | - | - | - | - | 1.37B | |
| -1569x | 2.19x | 14.12x | - | - | - | - | 1.34B | |
| 24.98x | 4.19x | 0.67x | 6.1x | 17.43x | 19.42x | 1.2% | 1.2B | |
| 14.58x | 1.76x | 5.25x | - | - | - | 2.97% | 1.12B | |
| -37.78x | 2.37x | 0.14x | - | - | - | - | 1.12B | |
| Average | -90.88x | -0.09x | 5.13x | 5.80x | 12.62x | -5.04x | 1.45% | 4.08B | |
| Weighted average by Cap. | -28.60x | -5.99x | 4.29x | 7.53x | 7.08x | -24.04x | 1.08% |
- Stock Market
- Equities
- MYGN Stock
- Sector Myriad Genetics, Inc.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
